Abstract
The degradation of doxorubicin in acidic medium has been investigated using a stability indicating high pressure liquid chromatographic assay. Influences of temperature, pH and ionic strength on the degradation rate are quantified. The stability of doxorubicin at 50°C is compared with those of seven related anthracyclines. The aglycone degradation products are characterized by mass spectrometry and by chromatography.
Similar content being viewed by others
References
Davis HL, Davis TE. Daunorubicin and adriamycin in cancer treatment: An analysis of their roles and limitations. Cancer Treat Rep 1979;63:809–15.
Crooke ST, Reich SD. Anthracyclines: current status and new developments. New York: Academic Press, 1980.
Carter SK. Adriamycin — A review. J Natl Cancer Inst 1975;55:1265–73.
Barbieri B, Bellini O, Savi G, Bertazolli C, Penco S, Casazza AM. Antitumour activity and cardiotoxicity of new 4-demethoxyanalogues of daunorubicin and doxorubicin. Drugs Exptl Clin Res 1984;10:85–90.
Formelli F, Casazza AM. Biological and pharmacological properties of new anthracycline derivatives. Drugs Exptl Clin Res 1984;10:75–84.
Harper H, Kemeny N, Cheng E, Sordillo P, Ahmed T. Phase II trial of 4-demethoxydaunorubicin (DMDR) in advanced colorectal carcinoma. Proc Am Assoc Cancer Res 1983;24:148.
Ferrari L, Rossi A, Brambilla C, et al. Phase I study with 4′-deoxydoxorubicin. Proc Am Assoc Cancer Res 1983;24:163.
Arcamone F, Franceschi G, Penco S. Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic. Tetrahedron Letters 1969;13:1007–10.
Wassermann K, Bundgaard H. Kinetics of the acidcatalyzed hydrolysis of doxorubicin. Int J Pharm 1983;14:73–8.
Tavoloni N, Guarino AM, Berk PD. Photolytic degradation of adriamycin. J Pharm Pharmacol 1980;32: 860–2.
Daugherty JP, Hixon SC. Photolytic destruction of adriamycin. J Pharm Pharmacol 1981;33:556.
Thoma K, Strittmatter T, Steinbach D. Untersuchungen zur Photoinstabilität von Antibiotika. Acta Pharm Techn 1980;26:269–72.
Williams BA, Tritton TR. Photoinactivation of anthracyclines. Photochem Photobiol 1981;34:131–4.
Karlsen J, Thønessen HH, Olsen IR, Sollien AH, Skobba TJ. Stability of cytotoxic intravenous solutions subjected to freeze-thaw treatment. Nor Pharm Acta 1983;45:61–7.
Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL. Stability and compatibility of antitumor agents in glass and plastic containers. Am J Hosp Pharm 1981;38:1914–8.
Hoffman DM, Grossano DD, Damin LA, Woodcock TM. Stability of refrigerated and frozen solutions of doxorubicin hydrochloride. Am J Hosp Pharm 1979;36:1536–8.
Poochikian GK, Cradock JC, Flora KP. Stability of anthracycline antitumor agents in four infusion fluids. Am J Hosp Pharm 1981;38:483–6.
Ketchum D, Wolf E, Sesin GP. Cost benefit and stability study of doxorubicin following reconstitution. Am J Intrav Ther Clin Nutr 1981:15–8.
Eksborg S, Ehrsson H, Wallin I, Lindfors A. Quantitative determination of adriamycin and daunorubicinhandling of blood and plasma samples. Acta Pharm Suec 1981;18:215–20.
Schwartz HS, Paul B. Biotransformations of daunorubicin aglycones by rat liver microsomes. Cancer Res 1984;44:2480–4.
Schwartz HS, Parker NB. Initial biotransformations of daunorubicin to aglycones by rat liver microsomes. Cancer Res 1981;41:2343–8.
Bates RG. Determination of pH theory and practice. 2nd ed. New-York-London-Sydney-Toronto: John Wiley & Sons, 1973.
Tomlinson E, Malspeis L. Concomitant adsorption and stability of some anthracycline antibiotics. J Pharm Sci 1982;71:1121–5.
Aszalos A. Analysis of antitumor antibiotics by high pressure liquid chromatography (HPLC). J Liq Chromatogr 1984;7(S-1):69–125.
Sturgeon RJ, Schulman SG. Electronic absorption spectra and protolytic equilibria of doxorubicin: direct spectrophotometric determination of microconstants. J Pharm Sci 1977;6:958–61.
Arcamone F, Franceschi G, Orezzi P, Cassinelli G, Barbieri W, Mondelli R. Daunomycin. I. The structure of daunomycinone. J Am Chem Soc 1904;86:5334–5.
Gioia B, Arlandini E, Vigevani A. Field desorption mass spectrometry of anthracyclines. Comparison with other soft ionization techniques. Biomed Mass Spectrom 1984;11:35–40.
Roller PP, Sutphin M, Aszalos AA. Mass spectrometry of N-acylated daunorubicin derivatives. Biomed Mass Spectrom 1976;3:166–71.
Watson E, Chan KK. GLC-Mass spectrometry of several important anticancer drugs I: Pertrimethylsilylation andO-methoxime formation. J Pharm Sci 1978;67:1243–6.
Vigevani A, Gioia B, Cassinelli G. Mass spectrometry of some N-acyldaunosamine derivatives. Carbohydr Res 1974;32:321–30.
Smith RG. Characterization of anthracycline antibiotics by desorption chemical ionization mass spectrometry. Anal Chem 1982;54:2006–8.
Menozzi M, Valentini L, Vannini E, Arcamone F. Self-association of doxorubicin and related compounds in aqueous solution. J Pharm Sci 1984;73:766–70.
Chaires JB, Dattagupta N, Crothers DM. Self-association of daunomycin. Biochemistry 1982;21:3927–32.
Miyamoto E, Odashima S, Kitagawa I, Tsuji A. Stability kinetics of ginsenosides in aqueous solution. J Pharm Sci 1984;73:409–10.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beijnen, J.H., Wiese, G. & Underberg, W.J.M. Aspects of the chemical stability of doxorubicin and seven other anthracydines in acidic solution. Pharmaceutisch Weekblad Scientific Edition 7, 109–116 (1985). https://doi.org/10.1007/BF01968712
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01968712